This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Anne Kjersti Befring and Cecilia Marcela Bailliet Introduction The COVID-19 pandemic posed a grave threat to humanity and revealed the need for a new approach to improve transnational cooperation within the global health system and new perspectives on solidarity addressing the cross-border spread of infection and distribution of vaccines.
Estimates of the number of persons with disabilities affected by the 2022 floods in Bangladesh by the United Nations Humanitarian Coordination Task Team appear unbelievably low compared with WorldHealth Organization estimates. Here, the United Nations Committee on the Rights of Persons with Disabilities has a critical role to play.
The Health Pavilion at COP29 represented the momentum that has been building since COP16 to acknowledge the climate-health nexus within the UNFCCC. The post COP29 and the UNFCCCs Health Turn: Progress or Peril? Yet this progress was not abstracted from the structural bias shaping the broader climate governance regime.
By Rossella De Falco Strong, well-coordinated and resilient publichealth care services play a vital role in preventing and responding to publichealth crises. What are, however, the specific legal and ethical implications of involving private actors in health care vis-à-vis publichealth emergencies?
“I’m in Berlin, and we don’t like walls,” Bart De Witte responded in a concluding Q&A session yesterday at the 2 nd Symposium on the Future of Health Systems, convened by the WorldHealth Organization (WHO) in Porto on 5 th September. For health care in the U.S.
By Roojin Habibi, Timothy Fish Hodgson, and Alicia Ely Yamin Today, as the world transitions from living in the grips of a novel coronavirus to living with an entrenched, widespread infectious disease known as COVID-19, global appreciation for the human rights implications of publichealth crises are once again rapidly fading from view.
Three reports published in the past few weeks give us some useful perspective on that question, woven together in today’s Health Populi blog. Let’s start with the Philips Future Health Index , which assesses value to 16 national health systems through three lenses: access, satisfaction, and efficiency.
This year-end/New Year 2022 post on my Health Populi blog will weave together many of the key findings from these consumer health/care reports that are most resonating with me and the work I’m doing…. We’ve seen more financial and money-focused media bringing health care cost stories under their mastheads.
Extensive abuses of human rights during the pandemic led international experts to draft the Principles and Guidelines on Human Rights and PublicHealth Emergencies (HR Principles). The inadequacy of Siracusa in the the context of publichealth emergencies Then came COVID-19.
The legal and institutional regime aimed at preventing and controlling the spread of infectious diseases, grounded on the International Health Regulations (IHR) was heavily criticized. The alarm mechanism based on the declaration of PublicHealth Emergency of International Concern (PHEIC), in particular, has been severely tested.
This week, publichealth truths have collided with social media, the infodemic, and health citizenship. First, I read in Becker’s Health IT on February 16 that the peer-reviewed policy journal Health Affairs was prevented by a social media outlet from promoting its February 2022 issue themed “Racism and Health.
It has been an important forum for enabling States to address the fault lines in national publichealth systems, bridge gaps in global health security and policy, and strengthen collective efforts to build back better. Supply chains must be strengthened, diversified, and kept open during publichealth emergencies.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the WorldHealth Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. States can no longer pretend not to know this.
The high-deductible health plan design in fact prevents many people from seeking preventive care or testing: uninsured patients could pay at least $500 for a test, and a 10-day hospital stay can tally $75,000 according to Gerard Anderson , professor of publichealth at Johns Hopkins.
By Calvin Wai-Loon Ho With the mainstreaming of digital technology across many spheres of social life, infodemic management must be an integral part of publichealth emergency prevention, preparedness, response, and recovery.
I welcome and dig into the Edelman Trust Barometer every year, and put on my health/care lens when reviewing its findings. In this Health Populi blog, I’ll cover the global results and some of the granular health-related nuggets I can divine from this overall world-view. In the U.S.
A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest WorldHealth Organization (WHO) guidelines. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.
The adoption of these mechanisms is recommended and encouraged by the WorldHealth Organization (WHO) so that the population has faster access to health services and technologies. These variations are required to be assessed by the authorities based on their impact on publichealth and the medicine’s characteristics.
WorldHealth Organization (WHO) WHO: Excipients GMP Guideline Published for Comments, 03 May 2023 In March 2023, the WHO published the first draft of the guideline WHO Good Manufacturing Practices for Excipients Used in Pharmaceutical Products on its website for comments. Floor 9, No.
WorldHealth Organization (WHO) WHO: Excipients GMP Guideline Published for Comments, 03 May 2023 In March 2023, the WHO published the first draft of the guideline WHO Good Manufacturing Practices for Excipients Used in Pharmaceutical Products on its website for comments. Floor 9, No.
It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between publichealth authorities. Its ambition is to create more opportunities for patients across the European Union (EU) to access the treatment they need independently of where they live.
While summarizing the entire content of the 13 blogs comprising this symposium in any depth is not possible here, this concluding post will attempt to synthesize some of the major inputs from the contributions. They also were intended to be of application to a wide range of emergencies, not publichealth emergencies specifically.
In addition, it contains essential recommendations to avoid complications and protect publichealth. Aimed at both consumers and professionals of aesthetic clinics, the alert clarifies the precautionary ban on certain products. Analysts documented original laboratory data on uncontrolled sheets of paper.
In addition, it contains essential recommendations to avoid complications and protect publichealth. Aimed at both consumers and professionals of aesthetic clinics, the alert clarifies the precautionary ban on certain products. Analysts documented original laboratory data on uncontrolled sheets of paper.
This week marks the two-year anniversary of WorldHealth Organization Director-General Tedros Adhanom declaring COVID-19 a pandemic. thus has reverberating repercussions: it strips away not only necessary publichealth precautions, but also hard-won adaptations, such as remote work and more generous sick leave policies.
NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding publichealth.
In Australia, medicines and chemicals are classified into schedules according to the level of regulatory control required to protect publichealth and safety. Schedule 10 lists substances of such danger to publichealth as to warrant their prohibition from supply and use. the “WeFun” product is an unapproved new drug).
NPMA Issues Draft Guidelines for Inspection of Medical Device Clinical Trial Sites, 14 June 2024 China NMPA has released a new guideline that aims to enhance the management of clinical trial institutions for medical devices, ensuring compliance with regulatory standards and safeguarding publichealth.
In Australia, medicines and chemicals are classified into schedules according to the level of regulatory control required to protect publichealth and safety. Schedule 10 lists substances of such danger to publichealth as to warrant their prohibition from supply and use. the WeFun product is an unapproved new drug).
It rapidly caused a widespread epidemic in China and has spread to over 50 countries outside of China with more than 90,000 confirmed cases and 3000 deaths at the time of this blog article. Secretary of the Department of Health and Human Services (HHS) has declared a publichealth emergency.
Wolf With our recent (and continuing) experience of the devastating COVID-19 global pandemic, one might think that our collective appreciation for publichealth efforts and the people advancing those efforts would be high. An essential first step is to refocus on the “public” in publichealth.
Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules. Last year, the WorldHealth Organization (WHO) issued an alert about cough syrups being contaminated with diethylene glycol and ethylene glycol, which are toxic to humans and can prove fatal.
726/2004, the Commission can grant a duplicate marketing authorization: If there are objective, verifiable reasons relating to publichealth that show an increased availability of medicinal products to healthcare professionals and/or patients. WorldHealth Organization (WHO). Under Article 82(1) of Regulation (EC) No.
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the WorldHealth Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Publichealth emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.
The Health Pavilion at COP29 represented the momentum that has been building since COP16 to acknowledge the climate-health nexus within the UNFCCC. The post COP29 and the UNFCCCs Health Turn: Progress or Peril? first appeared on Bill of Health. Alicia Ely Yamin J.D.,
The UK sees the plans as an opportunity to introduce new regulations after Brexit in order to strengthen the publichealth sector. WorldHealth Organization (WHO). These plans concern both medical devices and in vitro diagnostics. The aim is to promote patient safety and innovation.
by Elena Caruso While the exact definition of self-managed abortion remains blurred , it currently tends to refer to the end of a pregnancy through the autonomous administration of pills outside of a publichealth facility.
Two years ago tomorrow, Norton Rose Fulbright shared the first of its many blog updates regarding the Coronavirus and the global pandemic that was about to unfold. We have watched the United States declare a publichealth emergency. The post COVID-19 Update: More Reflections on a Pandemic appeared first on Health Law Pulse.
An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19 vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, WorldHealth Organization (“WHO”), or if administered as a part of a clinical trial. Notice to Employees.
Judicial independence is also critical for publichealth. Over the last century, courts have affirmed broad publichealth powers and established modern health-related rights. This term, the Court will rule on issues at the heart of health equity, and the outcomes are sadly predictable.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content